BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1007 related articles for article (PubMed ID: 16448580)

  • 1. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The S-enantiomer of R,S-citalopram, increases inhibitor binding to the human serotonin transporter by an allosteric mechanism. Comparison with other serotonin transporter inhibitors.
    Chen F; Larsen MB; Sánchez C; Wiborg O
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):193-8. PubMed ID: 15695064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter].
    Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N
    Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.
    Nagayasu K; Yatani Y; Kitaichi M; Kitagawa Y; Shirakawa H; Nakagawa T; Kaneko S
    Br J Pharmacol; 2010 Dec; 161(7):1527-41. PubMed ID: 20698856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escitalopram, an antidepressant with an allosteric effect at the serotonin transporter--a review of current understanding of its mechanism of action.
    Zhong H; Haddjeri N; Sánchez C
    Psychopharmacology (Berl); 2012 Jan; 219(1):1-13. PubMed ID: 21901317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interaction of escitalopram and R-citalopram at the human serotonin transporter investigated in the mouse.
    Jacobsen JP; Plenge P; Sachs BD; Pehrson AL; Cajina M; Du Y; Roberts W; Rudder ML; Dalvi P; Robinson TJ; O'Neill SP; Khoo KS; Morillo CS; Zhang X; Caron MG
    Psychopharmacology (Berl); 2014 Dec; 231(23):4527-40. PubMed ID: 24810106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein Kinases Alter the Allosteric Modulation of the Serotonin Transporter In Vivo and In Vitro.
    Mnie-Filali O; Lau T; Matthaeus F; Abrial E; Delcourte S; El Mansari M; Pershon A; Schloss P; Sánchez C; Haddjeri N
    CNS Neurosci Ther; 2016 Aug; 22(8):691-9. PubMed ID: 27171685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allosteric effects of R- and S-citalopram on the human 5-HT transporter: evidence for distinct high- and low-affinity binding sites.
    Plenge P; Gether U; Rasmussen SG
    Eur J Pharmacol; 2007 Jul; 567(1-2):1-9. PubMed ID: 17499240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venlafaxine: discrepancy between in vivo 5-HT and NE reuptake blockade and affinity for reuptake sites.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Synapse; 1999 Jun; 32(3):198-211. PubMed ID: 10340630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
    David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM
    Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
    Sanchez C; Reines EH; Montgomery SA
    Int Clin Psychopharmacol; 2014 Jul; 29(4):185-96. PubMed ID: 24424469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain.
    El Mansari M; Sánchez C; Chouvet G; Renaud B; Haddjeri N
    Neuropsychopharmacology; 2005 Jul; 30(7):1269-77. PubMed ID: 15702136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered response to the selective serotonin reuptake inhibitor escitalopram in mice heterozygous for the serotonin transporter: an electrophysiological and neurochemical study.
    Guiard BP; Mansari ME; Murphy DL; Blier P
    Int J Neuropsychopharmacol; 2012 Apr; 15(3):349-61. PubMed ID: 21439106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
    Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
    J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An allosteric binding site at the human serotonin transporter mediates the inhibition of escitalopram by R-citalopram: kinetic binding studies with the ALI/VFL-SI/TT mutant.
    Zhong H; Hansen KB; Boyle NJ; Han K; Muske G; Huang X; Egebjerg J; Sánchez C
    Neurosci Lett; 2009 Oct; 462(3):207-12. PubMed ID: 19616061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second-generation SSRIs: human monoamine transporter binding profile of escitalopram and R-fluoxetine.
    Owens MJ; Knight DL; Nemeroff CB
    Biol Psychiatry; 2001 Sep; 50(5):345-50. PubMed ID: 11543737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse strain differences in SSRI sensitivity correlate with serotonin transporter binding and function.
    Jin ZL; Chen XF; Ran YH; Li XR; Xiong J; Zheng YY; Gao NN; Li YF
    Sci Rep; 2017 Aug; 7(1):8631. PubMed ID: 28819255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allosteric modulation of the effects of the 5-HT reuptake inhibitor escitalopram on the rat hippocampal synaptic plasticity.
    Mnie-Filali O; El Mansari M; Espana A; Sànchez C; Haddjeri N
    Neurosci Lett; 2006 Feb; 395(1):23-7. PubMed ID: 16330146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Further evidence for the importance of 5-HT1A autoreceptors in the action of selective serotonin reuptake inhibitors.
    Hjorth S; Auerbach SB
    Eur J Pharmacol; 1994 Aug; 260(2-3):251-5. PubMed ID: 7988652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.